Evan Norton
Adjunct Lecturer in Healthcare at Kellogg
Evan Norton is Divisional Vice President and leads Abbott Ventures (AVI) based in Abbott Park, Illinois. He joined AVI in 2010. Previously, he was a Principal with ONSET Ventures focused on medical technology investing. He has a diverse background of operating experience in medical technology including the endoscopy, diabetes and ear, nose and throat markets having worked for Stryker Endoscopy, J&J LifeScan and Acclarent.
In addition to his medical device experience, Evan worked for Compaq Computer Corporation's Strategic Investments group, the Investment Banking Group at J.P. Morgan Chase & Co and in the consulting practice at PriceWaterhouseCoopers.
Evan holds an MBA degree from the J.L. Kellogg Graduate School of Management and a BBA in Finance from Texas A&M University. He currently serves on the Innovation and New Ventures Advisory Board at Northwestern.
-
-
-
MBA, 2002, Northwestern University
B.A., 1996, Finance, Texas A&M University, cum laude -
Divisional Vice President, Abbott Ventures, INC., 2010-present
Principal, Onset Ventures, 2007-2010
Marketing Manager, Acclarent, INC., 2007
Marketing Manager, Lifescan, INC., 2003-2007
Product Manager, Stryker Corporation, 2002-2003
Strategic Investments/Corporate Development Intern, Compaq Computer Corporation
Global Investment Banking Associate/Analyst, JPMorgan Chase, 1998-2000
Management Consultant, Pricewaterhousecoopers LLP, 1996-1998
Healthcare Entrepreneurship Lab (HCAK-937-0)
The Healthcare Entrepreneurship Lab offers a unique opportunity for students to be part of a local early-stage healthcare company. Students apply the foundational learnings from Kellogg's strategic training to address real and complex entrepreneurial challenges in healthcare. Students are guided by the Kellogg instructors and the company's executive. Instructors bring extensive experience as investors and entrepreneurs in the medical device, health IT, and pharma/biotech areas.
Students work with a startup (medical devices, digital health, biotech/pharma, services) on a mutually agreed project and work plan. The project will be strategically important to the company and will benefit from the students' knowledge and broad perspective gained from their studies at Kellogg.
All projects are selected and uniquely designed to expose students to the challenges of an early-stage health care company and at the same time provide a unique learning experience not fully available in other courses at Kellogg. It is geared towards students with a serious interest in entering the world of early-stage health care companies either as an entrepreneur or early-stage investor and who are seeking real life experiences and industry contacts.
Medical Technology Financing and Commercialization (HCAK-611-0)
This course offers students an experiential learning opportunity to work directly in the commercialization and fundraising process for innovative, pre-commercial medical technologies, to include devices, diagnostics, services and software solutions. The insights from this hands-on course will be most beneficial to students with an interest in entrepreneurship, start-ups, product design, early stage financing and product marketing. Students will be placed on three-to-four member teams based on their skills, experience and project interests. Each team will function as members of the executive team working with select Northwestern tech transfer companies curated by Northwestern's INVO (Innovation and New Ventures Office). Each company will present their technology on the first day of class, after which students will rank their top choices and will be matched by the faculty to meet top preferences. Once matched, students will work with their respective companies to build a complete investor deck that will be delivered to a panel of industry and finance experts at the end of the quarter. Each class includes a faculty lecture and guest lecture in an effort to bring real world experiences and perspectives to each topic. Since its inception, this course has produced companies that competed in and won prestigious business plan competitions. It has also graduated several technologies/companies that are now FDA cleared and commercially available.
Note: This course may not be dropped after the first week of the quarter.
Field Study (HCAK-498-0)
Field Studies include those opportunities outside of the regular curriculum in which a student is working with an outside company or non-profit organization to address a real-world business challenge for course credit under the oversight of a faculty member. This course is for 1 credit unit.
Field Study (ENTR-498-5)
Field Studies include those opportunities outside of the regular curriculum in which a student is working with an outside company or non-profit organization to address a real-world business challenge for course credit under the oversight of a faculty member.
